About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,503 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,503 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4541-4560 of 7,503 trials

TerminatedStudy of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)The purpose of this study is to assess the efficacy and safety of the combination of pembrolizumab (MK-3475) and enzalutamide in the treatment of men with metastatic…NCT03834493·Mobile, Alabama and 258 others

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

TerminatedCJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene MutationsThis phase II trial tests how well abiraterone acetate/niraparib (CJNJ-67652000 \[niraparib/abiraterone acetate fixed-dose combination\]) and prednisone works in treating patients…NCT05689021·Scottsdale, Arizona and 2 others

CompletedTrans-Rectal Ultrasound-Guided (TRUS) Adverse EventsThe goal of this study is to identify any side effects caused by the implanting of markers via the rectum.NCT00923416·Toronto, Ontario

TerminatedTreatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to BonesThis phase II trial studies the effect of Sn-117m-DTPA on bone pain in patients with prostate cancer that has spread to the bones.NCT04616547·Lexington, Kentucky

WithdrawnAndrogen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART StudyThis phase II trial studies how well androgen deprivation therapy and apalutamide with or without radiation therapy works for the treatment of prostate cancer that has a rise in…NCT04585932·Houston, Texas

UnknownEvaluation of PSA Blood Levels Prior to and After Digital Rectal ExaminationPatients with know prostate cancer (PCa) under active surveillance and aged matched controls without evidence of PCa will have a PSA blood test prior to and following standardized…NCT02747563·Rehovot

TerminatedFeasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)The purpose of this study is the development of noninvasive (having no direct contact) detector and electronic system that will directly measure tumor blood flow rate.NCT01987193·Jacksonville, Florida

CompletedSystemic and Tumor-Directed Therapy for Oligometastatic Prostate CancerThis is a trial for patients with newly diagnosed metastatic prostate cancer with 5 or fewer sites of metastases.NCT03298087·Long Beach, California and 2 others

CompletedMy Health Day by Day (Mi Salud Dia a Dia)The purpose of this study is to is to evaluate how Cognitive Behavioral Stress Management (CBSM) targets (e.g., anxiety reduction, cognitive reappraisal, coping, emotional…NCT04545021·Miami, Florida

CompletedTisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsThe purpose of the trial is to establish the tolerability of tisotumab vedotin (HuMax-TF-ADC) dosed three times every four weeks (3q4wk) in a mixed population of patients with…NCT02552121·Houston, Texas and 15 others

CompletedPET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy VolunteersVisual assessment of diagnostic PET/CT (positron emission tomography/computed tomography) images obtained after a single intravenous injection of BAY86-7548 in patients with…NCT01205321·Turku and 2 others

CompletedSafety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)This is a two part study of the drug MK-8669 (ridaforolimus) given with MK-2206 or MK-0752.NCT01295632

RecruitingSequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant CancerThe goal of this clinical trial is to evaluate the safety and effectiveness of a novel diagnostic strategy for prostate cancer, in which men with a moderate risk of prostate…NCT07180381·Emmen, Drenthe and 6 others

RecruitingStudy of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)The goal of this study is to determine whether the addition of Androgen Deprivation Therapy (ADT) utilizing the study drug ELIGARD® to Recurrence- Directed Therapy (RDT) improves…NCT06654336·Hamilton, Ontario and 2 others

CompletedStudy of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate CancerThe purpose of this study is to see if an intervention of antioxidants(vitamin E, selenium and lycopene) can change (reduce) prostate tumor size and alter certain markers that can…NCT00844792·Toronto, Ontario

RecruitingCharacterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer.NCT06960798·Oklahoma City, Oklahoma

CompletedMagnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate CancerRATIONALE: Imaging procedures such as magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) may improve the ability to detect the extent of prostate…NCT00032058·San Francisco, California and 7 others

WithdrawnMitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for RecurrenceRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy after surgery may kill more tumor cells.NCT00003858

TerminatedMolecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate CancerThis research trial studies molecular characterization of circulating tumor cells (CTCs) and circulating tumor (ct) deoxyribonucleic acid (DNA) in blood and plasma samples from…NCT02370355·Los Angeles, California

TerminatedAndrogen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells.NCT00651326·Calgary and 12 others

PreviousPage 228 of 376Next